NCT00206739View on ClinicalTrials.gov

Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

1,070

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
MalariaAnemia
Interventions
DRUG

Sulfadoxine (12.5 mg)/Pyrimethamine (250 mg)

Trial Locations (1)

Unknown

Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi

All Listed Sponsors
collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

Deutscher Akademischer Austausch Dienst

OTHER

collaborator

The Volkswagen Foundation

OTHER

lead

Bernhard Nocht Institute for Tropical Medicine

OTHER_GOV

NCT00206739 - Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants | Biotech Hunter | Biotech Hunter